OverviewChartNewsTraderScreen

Soc. Generale Knock-Out GILD/  DE000SW2V4Q1  /

EUWAX
11/8/2024  9:45:31 PM Chg.-0.04 Bid10:00:43 PM Ask10:00:43 PM Underlying Strike price Expiration date Option type
7.89EUR -0.50% -
Bid Size: -		 -
Ask Size: -		 Gilead Sciences Inc 54.6579 USD 12/31/2078 Call
GlobeNewswire 8/27 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 8/27 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 8/8 HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 8/8 Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
GlobeNewswire 8/8 Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results
GlobeNewswire 8/6 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
GlobeNewswire 8/5 89bio Reports Second Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire 8/5 89bio Appoints Charles McWherter, Ph.D., to its Board of Directors
GlobeNewswire 8/1 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire 7/23 ACTG Presents Data Analysis at AIDS 2024 Showing Association between Elevated Risk of Cardiovascular...
GlobeNewswire 7/15 Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inh...
GlobeNewswire 7/8 Memo Therapeutics AG appoints Paul Carter as Chairperson
GlobeNewswire 7/8 Memo Therapeutics AG appoints Paul Carter as Chairperson
GlobeNewswire 7/4 Burns McClellan Mourns the Passing of Founder and CEO, Lisa Burns
GlobeNewswire 7/1 HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment o...
GlobeNewswire 7/1 Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Offi...
GlobeNewswire 6/28 Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire 6/26 Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
GlobeNewswire 6/26 Oruka Therapeutics Announces Key Additions to Leadership Team and Board of Directors
TeleTrader 6/20 US opens mostly higher after labor, housing data
GlobeNewswire 6/18 Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation C...
GlobeNewswire 6/17 Assembly Biosciences Announces $12.6 Million in Equity Financings
GlobeNewswire 6/10 Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus He...
GlobeNewswire 5/22 Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congres...
GlobeNewswire 5/14 Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results